About the Role
San Francisco Bay Area (Peninsula/South Bay)
The ideal candidate is a results-oriented leader capable of delivering significant technology initiatives and outstanding IT support in a rapid growth environment to support Outset’s Business Intelligence/Analytics efforts. Outset is seeking a subject-matter expert to provide leadership for those involved in the development, design and optimization of one or more information technology and systems functions supporting company business processes and technical information systems platforms. Responsibilities include, but are not limited to, analysis, selection and modification of systems, application software, and installation of network hardware/software and database management. The Director, IT would provide direction for the effort required to protect the company’s data, tools and information systems and ensure infrastructure architecture standards maximize efficiency and support platform compatibility. S/he would develop and lead a high-performing team of IT professionals; foster a culture of collaboration and support through coaching and mentoring. Largely, this position requires a combination of strategic leadership, cloud-based knowledge, and relationship building skills to develop and implement world-class IT and security programs; broad technical knowledge and subject-matter expertise (technology, threat landscape, security, legal, policy, compliance, and identity and access management).
- Information Technology
- IT Management required
Less than 10%
About the Company
Outset Medical is a privately held company backed by a top-tier syndicate of investors, including Fidelity, T. Rowe Price, Perceptive Advisors, The Partner Fund, Mubadala and Warburg Pincus. We are a pioneering medical technology company focused on reducing the cost and complexity of dialysis. The company’s Tablo™ system is the consumer product version of what today is a terribly complex and prohibitively cumbersome machine for patients to use themselves. We combined consumer product simplicity, wireless data transmission and real-time integrated water purification to enable dialysis anytime, in any setting, managed by anyone. Tablo is the first new dialysis technology approved by FDA in over 15 years. Designed to dramatically improve the care experience for patients and the cost-efficiency for providers and payers, Tablo is aimed at enabling service model innovation in a space that has not fundamentally changed since the 1980s. The company is in the early stages of full commercial launch in US dialysis clinics and hospitals, with a clinical trial underway to expand FDA clearance to include the use of the device at home.
Privately Held, VC-backed